Jonathan Zalevsky

Chief R&D Officer

Chief R&D Officer at NEKTAR THERAPEUTICS, filing insider transactions between 2026-02-18 and 2026-06-30.

Total Purchases

—

0 transactions

Total Sales

$760K

4 transactions

Companies Traded

1

4 total filings

Active Since

2026-02-18

Last: 2026-06-30

Companies

NEKTAR THERAPEUTICS

Other Reporting Insiders at Nektar Therapeutics

Transaction History

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-06-30	NKTR	Sale	5,681	$70.00	$398K	9,756	SEC ↗
2026-06-15	NKTR	Sale	5,538	$60.71	$336K	15.4K	SEC ↗
2026-05-19	NKTR	Sale	199	$65.51	$13K	21.0K

Jonathan Zalevsky (Nektar Therapeutics) Insider Trades | Tormere